• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米诺环素治疗犬皮肤利什曼病的疗效:一项随机对照试验。

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.

机构信息

Immunology Service, Professor Edgard Santos University Hospital Complex, Federal University of Bahia, Salvador, Bahia, Brazil.

Post-Graduate Course in Health Sciences, Federal University of Bahia Medical School. Salvador, Bahia, Brazil.

出版信息

PLoS Negl Trop Dis. 2023 Feb 15;17(2):e0011064. doi: 10.1371/journal.pntd.0011064. eCollection 2023 Feb.

DOI:10.1371/journal.pntd.0011064
PMID:36791065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9931096/
Abstract

Dogs living in areas of Leishmania (Viannia) braziliensis transmission may present canine tegumentary leishmaniasis (CTL) characterized by cutaneous or muzzle ulcers as well as asymptomatic L. braziliensis infection. It is not clear if dogs participate in the transmission chain of L. braziliensis to humans. However, dogs may remain with chronic ulcers for a long time, and as there are no public policies about CTL, these animals die or are sacrificed. Here we compare the efficacy of intralesional meglumine antimoniate with intralesional 0.9% NaCl solution in CTL treatment. This randomized control study included 32 dogs with cutaneous or muzzle lesions who had L. braziliensis DNA detected by PCR in tissue biopsied. Group one received 5ml of intralesional Glucantime, and group two received 5ml 0.9% NaCl solution, both applied in the four cardinal points on days 0, 15, and 30. Cure was defined as complete healing of the ulcers in the absence of raised borders on day 90. There was no difference in animals' demographic and clinical features in the two groups (p >.05). While at the endpoint, the cure rate was 87.5% in the group test, and in those who received 0.9 NaCl the cure rate was only 12.5%. As important as the high cure rate, the healing time was faster in dogs treated with antimony than in those treated with saline (p < .001). Intralesional meglumine antimoniate is effective in the treatment of dogs with L. braziliensis infection and accelerates the healing time of CTL.

摘要

生活在莱什曼原虫(Viannia)巴西利ensis 传播区域的狗可能患有犬皮肤利什曼病(CTL),其特征是皮肤或口鼻溃疡以及无症状的巴西利ensis 感染。目前尚不清楚狗是否参与了巴西利ensis 向人类的传播链。然而,狗可能会长期患有慢性溃疡,而且由于没有针对 CTL 的公共政策,这些动物会死亡或被牺牲。在这里,我们比较了病灶内葡甲胺锑和病灶内 0.9%生理盐水溶液在 CTL 治疗中的疗效。这项随机对照研究纳入了 32 只患有皮肤或口鼻病变的狗,这些狗的组织活检中通过 PCR 检测到了巴西利ensis DNA。一组接受 5ml 病灶内 Glucantime,另一组接受 5ml 0.9%生理盐水溶液,均在第 0、15 和 30 天在四个方位点注射。治愈定义为第 90 天溃疡完全愈合且无隆起边缘。两组动物的人口统计学和临床特征无差异(p >.05)。虽然在终点时,实验组的治愈率为 87.5%,而接受 0.9%生理盐水的治愈率仅为 12.5%。除了高治愈率外,接受锑治疗的狗的愈合时间比接受生理盐水治疗的狗更快(p <.001)。病灶内葡甲胺锑对巴西利ensis 感染的狗有效,并加速了 CTL 的愈合时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/9931096/021852b7cbd9/pntd.0011064.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/9931096/05299f864d0c/pntd.0011064.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/9931096/021852b7cbd9/pntd.0011064.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/9931096/05299f864d0c/pntd.0011064.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/9931096/021852b7cbd9/pntd.0011064.g002.jpg

相似文献

1
Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.米诺环素治疗犬皮肤利什曼病的疗效:一项随机对照试验。
PLoS Negl Trop Dis. 2023 Feb 15;17(2):e0011064. doi: 10.1371/journal.pntd.0011064. eCollection 2023 Feb.
2
American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.美国皮肤利什曼病由对抗锑剂葡萄糖酸锑钠耐药但对喷他脒敏感的巴西利什曼原虫引起:病例报告。
Rev Soc Bras Med Trop. 2011 Mar-Apr;44(2):254-6. doi: 10.1590/s0037-86822011000200026.
3
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.巴西利什曼原虫前鞭毛体对葡甲胺锑酸盐(葡糖胺锑)的敏感性高于其他利什曼原虫物种,且与美洲皮肤利什曼病的治疗反应相关。
J Parasitol. 2007 Jun;93(3):688-93. doi: 10.1645/GE-1031R.1.
4
Leishmania (Viannia) braziliensis infection in two Colombian dogs: a note on infectivity for sand flies and response to treatment.两只哥伦比亚犬感染巴西利什曼原虫(维安尼亚亚属):关于对沙蝇的感染性及治疗反应的记录
Biomedica. 2006 Oct;26 Suppl 1:249-53. doi: 10.7705/biomedica.v26i1.1520.
5
Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.有效的葡甲胺锑酸盐病灶内治疗对全身应用脂质体两性霉素B难治的希克勒罗溃疡。
J Travel Med. 2021 Aug 27;28(6). doi: 10.1093/jtm/taaa169.
6
Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.巴西利什曼原虫(维安亚属)巴西种和圭亚那种所致皮肤利什曼病在巴西的比较:对葡甲胺锑酸盐的治疗反应
Am J Trop Med Hyg. 2001 Nov;65(5):456-65. doi: 10.4269/ajtmh.2001.65.456.
7
American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.巴西皮肤利什曼病:全身性葡甲胺锑治疗的当前方法的批判性回顾及替代治疗的短期可能性
Trop Med Int Health. 2019 Apr;24(4):380-391. doi: 10.1111/tmi.13210. Epub 2019 Feb 19.
8
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.联合冷冻疗法与病灶内注射葡甲胺锑酸盐(葡酸锑钠)对比单独使用冷冻疗法和病灶内注射葡甲胺锑酸盐(葡酸锑钠)治疗皮肤利什曼病的疗效比较研究
Int J Dermatol. 2004 Apr;43(4):281-3. doi: 10.1111/j.1365-4632.2004.02002.x.
9
[A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].[葡糖酸锑钠BP 88R与葡甲胺锑酸盐治疗皮肤利什曼病的比较研究。I.疗效与安全性]
Rev Soc Bras Med Trop. 1999 Jul-Aug;32(4):383-7. doi: 10.1590/s0037-86821999000400008.
10
Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial.局部应用 rSm29 联合静脉注射葡萄糖酸锑钠治疗皮肤利什曼病:一项随机对照试验。
Int J Infect Dis. 2024 Oct;147:107206. doi: 10.1016/j.ijid.2024.107206. Epub 2024 Aug 13.

引用本文的文献

1
Efficacy of meglumine antimoniate treatment on boxer skin lesions: case report.葡甲胺锑酸盐治疗拳击手皮肤病变的疗效:病例报告。
Front Vet Sci. 2025 Jun 30;12:1600004. doi: 10.3389/fvets.2025.1600004. eCollection 2025.
2
Dogs Harbor and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis.狗是人类皮肤利什曼病传播周期的宿主并参与其中。
Pathogens. 2023 Jul 27;12(8):981. doi: 10.3390/pathogens12080981.
3
Effect of Local Administration of Meglumine Antimoniate and Polyhexamethylene Biguanide Alone or in Combination with a Toll-like Receptor 4 Agonist for the Treatment of Papular Dermatitis due to in Dogs.

本文引用的文献

1
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.巴西一项评估米替福新与局部粒细胞巨噬细胞集落刺激因子治疗巴西利什曼原虫引起的皮肤利什曼病的双盲、随机试验。
Clin Infect Dis. 2021 Oct 5;73(7):e2465-e2469. doi: 10.1093/cid/ciaa1337.
2
Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.犬皮肤利什曼病的临床和组织病理学特征及犬利什曼原虫巴西利什曼原虫的分子特征。
PLoS Negl Trop Dis. 2019 Jul 16;13(7):e0007532. doi: 10.1371/journal.pntd.0007532. eCollection 2019 Jul.
3
葡甲胺锑酸盐和聚六亚甲基双胍单独或与Toll样受体4激动剂联合局部给药治疗犬疥疮所致丘疹性皮炎的效果
Pathogens. 2023 Jun 10;12(6):821. doi: 10.3390/pathogens12060821.
4
Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.更正:注射用葡甲胺锑酸盐治疗犬皮肤利什曼病的疗效:一项随机对照试验。
PLoS Negl Trop Dis. 2023 Apr 5;17(4):e0011261. doi: 10.1371/journal.pntd.0011261. eCollection 2023 Apr.
Comparison between systemic and intralesional meglumine antimoniate therapy in a primary health care unit.
在一个初级卫生保健单位中进行的葡甲胺锑酸盐全身治疗与病灶内治疗的比较。
Acta Trop. 2019 May;193:176-182. doi: 10.1016/j.actatropica.2019.03.007. Epub 2019 Mar 6.
4
Safety and efficacy of miltefosine monotherapy and pentoxifylline associated with pentavalent antimony in treating mucosal leishmaniasis.米替福新单药治疗与戊五价锑联合己酮可可碱治疗黏膜利什曼病的安全性和疗效。
Expert Rev Anti Infect Ther. 2018 Mar;16(3):219-225. doi: 10.1080/14787210.2018.1436967. Epub 2018 Feb 16.
5
Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.早期皮肤利什曼病患者感染巴西利什曼原虫后,在锑剂治疗后表达增强的炎症反应。
J Infect Dis. 2018 Feb 14;217(5):840-850. doi: 10.1093/infdis/jix627.
6
Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.分子流行病学及体外实验证据表明,巴西利什曼原虫菌株有助于判定美洲皮肤利什曼病患者对锑剂的反应。
Acta Trop. 2018 Feb;178:34-39. doi: 10.1016/j.actatropica.2017.10.010. Epub 2017 Oct 16.
7
Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis.口服己酮可可碱联合五价锑:皮肤利什曼病的一项随机试验
Am J Trop Med Hyg. 2017 May;96(5):1155-1159. doi: 10.4269/ajtmh.16-0435.
8
Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.在巴西利什曼原虫流行地区皮肤利什曼病的非典型表现:临床、免疫学和寄生虫学方面
PLoS Negl Trop Dis. 2016 Dec 1;10(12):e0005100. doi: 10.1371/journal.pntd.0005100. eCollection 2016 Dec.
9
Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial.氟康唑治疗巴西利什曼原虫引起的皮肤利什曼病:一项随机对照试验。
Clin Infect Dis. 2017 Jan 1;64(1):67-71. doi: 10.1093/cid/ciw662. Epub 2016 Nov 1.
10
Leishmania (Viannia) braziliensis in dogs in Brazil: epidemiology, co-infection, and clinical aspects.巴西犬体内的巴西利什曼原虫(维安亚利什曼原虫):流行病学、合并感染及临床特征
Genet Mol Res. 2015 Oct 5;14(4):12062-73. doi: 10.4238/2015.October.5.19.